title: Hepatitis B leading to hepatocellular carcinoma: calculating the risk.
authors.forename: J M
authors.initials: JM
authors.lastname: Puliyel
authors.forename: V
authors.initials: V
authors.lastname: Taneja
authors.forename: K
authors.initials: K
authors.lastname: Jindal
authors.forename: N
authors.initials: N
authors.lastname: Thomas
mesh_terms: D000328:Adult; D006528:Carcinoma, Hepatocellular / Q000453:epidemiology / Q000517:prevention & control*; D015897:Comorbidity; D005260:Female; D006509:Hepatitis B / Q000453:epidemiology / Q000517:prevention & control*; D017325:Hepatitis B Vaccines / Q000008:administration & dosage*; D006801:Humans; D017589:Immunization Programs / Q000458:organization & administration*; D007194:India / Q000453:epidemiology; D007231:Infant, Newborn; D008113:Liver Neoplasms / Q000453:epidemiology / Q000517:prevention & control*; D008297:Male; D016730:Program Development; D015397:Program Evaluation; D018570:Risk Assessment
chemical_list: D017325:Hepatitis B Vaccines